MegaMegaTypeType
A high-contrast sans-serif originally conceived for pharmaceutical packaging, redesigned in 2025 with a new Condensed subfamily, variable font width axis and support for over 230 languages across 37 styles.
About
TT Drugs distinguishes itself through pronounced stroke contrast and narrow terminals, with subtle curves on the upper stems of letters such as 'n', 'm' and 'r' that soften its otherwise authoritative tone. First released in 2014 and substantially rebuilt from 2023 onwards, version 2.100 adds 18 condensed styles and expands the variable font to three axes including width. Its 834 characters per style and 27 OpenType features make it well-suited to branding, packaging and editorial work across Latin and Cyrillic scripts.
Classification
Despite the page describing it as a serif at one point, TT Drugs is explicitly a sans-serif with high stroke contrast and narrow terminals rather than conventional serifs. Its elevated contrast and refined terminals place it in the high-contrast sans category, related to optical serif traditions without the actual serif forms.